Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

Trading Update

6 Jul 2017 07:00

RNS Number : 2582K
Swallowfield PLC
06 July 2017
 

6 July 2017

Swallowfield plc

("Swallowfield" or the "Group")

 

Trading update and notice of results

 

Swallowfield plc, a market leader in the development, formulation, and supply of personal care and beauty products, including its own portfolio of brands, is pleased to provide a trading update for the 52 weeks ended on 24 June 2017.

 

Trading update

 

The Board is pleased to confirm that the business has continued to trade strongly. Overall revenues for the full year are expected to show growth of 36% (30% on a constant currency basis) to approximately £74.1m (2016: £54.5m). Revenues excluding acquisitions are expected to show a growth of 7% (2% on a constant currency basis).

 

Revenue growth has been bolstered by the continuing strong performance of owned brands, in particular, the Brand Architekts' portfolio acquired in June 2016. In the Group's manufacturing business, revenues continued to perform solidly on the back of a stream of innovative new product launches.

 

As a result, underlying business performance* is expected to be significantly ahead of the previous year and in line with market forecasts.

 

The Group's balance sheet has further strengthened during the period with strong cash generation and working capital controls leading to a net debt position of £3.7m as at 24 June 2017 (2016: £4.3m). This figure includes a term loan of £2.0m used as part of the financing for the acquisition of The Brand Architekts.

 

Chris How, Chief Executive of Swallowfield, commented:

 

"Whilst the retail and consumer markets remain challenging, it has been a year of tremendous progress for the Group with the successful execution of our stated strategy driving us to record levels of sales and underlying profitability. The acquisition of The Brand Architekts has delivered fully against our expectations and has been integrated smoothly and effectively into the Group. The manufacturing business continues to perform solidly in its own right and provide crucial support to the growth of our owned brands."

 

Notice of results

 

The Company expects to announce its results for the 52-week period ended 24 June 2017 on 19 September 2017.

 

* Underlying business performance is adjusted for the impact of provisions made in relation to long term share based incentives (anticipated to be approximately £1.7m) and amortisation of acquisition-related intangibles. The majority of the charge on share based incentives relates to awards made in 2014 and become exercisable towards the end of 2017. These share options were put in place in order to incentivise the Group's wider management team (including the executive directors of Swallowfield) and to ensure that their interests are aligned with shareholders. At the time, this incentive plan was introduced the average share price was 95p and since that time shareholders have been rewarded with a capital improvement of over 300% in addition to progressive dividend income.

 

For further information please contact:

Swallowfield plc

Chris How

 Chief Executive Officer

 01823 662 241

Mark Warren

 Group Finance Director

 01823 662 241

Alex Price

 N+1 Singer

 020 7496 3000

Josh Royston / Hilary Buchanan

 Alma PR

 020 8004 4218

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRAMMTMBMMTBR
Date   Source Headline
15th Mar 20217:00 amRNSHolding(s) in Company
12th Mar 20211:04 pmRNSHolding(s) in Company
11th Mar 20214:18 pmRNSHolding(s) in Company
9th Mar 20211:04 pmRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNSHalf-year Report
25th Nov 20202:52 pmRNSResult of AGM
19th Nov 202012:04 pmRNSDirector/PDMR Shareholding
26th Oct 20202:55 pmRNSAnnual Report and Accounts & Notice of AGM
15th Oct 20209:46 amRNSHolding(s) in Company
12th Oct 20203:41 pmRNSHolding(s) in Company
30th Sep 20204:24 pmRNSGrant of share options
29th Sep 20205:10 pmRNSHolding(s) in Company
29th Sep 20203:00 pmRNSHolding(s) in Company
29th Sep 20209:59 amRNSHolding(s) in Company
29th Sep 20209:53 amRNSDirector/PDMR Shareholding
28th Sep 20207:00 amRNSFinal Results
31st Jul 202011:10 amRNSHolding(s) in Company
21st Jul 20203:27 pmRNSHolding(s) in Company
21st Jul 202010:45 amRNSHolding(s) in Company
20th Jul 202010:21 amRNSHolding(s) in Company
17th Jul 202011:02 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSTrading Update and Board Succession
22nd May 20207:00 amRNSVesting of LTIP Award and Total Voting Rights
15th Apr 20207:00 amRNSAppointment of CFO
14th Apr 20207:00 amRNSTrading Update
10th Mar 20207:00 amRNSHalf-year Report
25th Feb 20207:00 amRNSBoard Changes
26th Nov 20195:44 pmRNSHolding(s) in Company
20th Nov 20191:03 pmRNSResult of AGM
20th Nov 20197:00 amRNSAGM Statement
6th Nov 20194:34 pmRNSAGM Proxy Form
25th Oct 20195:35 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20197:00 amRNSAppointment of Interim CEO
30th Sep 20197:00 amRNSFinal Results
28th Aug 20194:16 pmRNSUpdate on Change of Name
27th Aug 20196:00 pmRNSUpdate on Change of Name
27th Aug 20198:52 amRNSCompletion of Proposed Disposal and Change of Name
19th Aug 201912:50 pmRNSHolding(s) in Company
15th Aug 20199:17 amRNSHolding(s) in Company
31st Jul 201910:45 amRNSResult of General Meeting
15th Jul 20197:00 amRNSProposed Disposal of Manufacturing Business
12th Jul 201911:43 amRNSHolding(s) in Company
4th Jul 20193:41 pmRNSHolding(s) in Company
22nd May 201912:17 pmRNSHolding(s) in Company
13th May 20197:00 amRNSDirectorate Change
4th Apr 20196:29 pmRNSHolding(s) in Company
20th Mar 20193:17 pmRNSHolding(s) in Company
11th Mar 201911:59 amRNSHolding(s) in Company
7th Mar 20191:26 pmRNSHolding(s) in Company
5th Mar 20197:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.